zidovudine has been researched along with wr 1065 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, MM; Hardy, AW; Kajon, AE; McCash, CL; Olivero, OA; Poirier, MC; Shearer, GM; Swenberg, JA; Torres, SM; Upton, PB; Walker, DM; Walker, VE | 1 |
Braun, HM; Divi, K; Marrogi, A; Mitchell, JB; Olivero, OA; Ongele, MO; Poirier, MC | 1 |
2 other study(ies) available for zidovudine and wr 1065
Article | Year |
---|---|
WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.
Topics: Adenoviridae; Cell Line; Cytoplasm; Didanosine; Dideoxynucleotides; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV-1; Humans; Hypoxanthine Phosphoribosyltransferase; Influenza A virus; Influenza B virus; Intracellular Space; Lymphocytes; Mercaptoethylamines; Mutagenesis; Mutation; Phytohemagglutinins; Serotyping; Time Factors; Virus Replication; Zidovudine | 2009 |
Selective protection of zidovudine-induced DNA-damage by the antioxidants WR-1065 and tempol.
Topics: Antioxidants; Apoptosis; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Chromatin; Chromosomes; Cyclic N-Oxides; Cytochalasin B; DNA Damage; Humans; Mercaptoethylamines; Micronucleus Tests; Mutagens; Necrosis; Radiation-Protective Agents; Spin Labels; Zidovudine | 2014 |